Clinical Trial Update: Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing etoricoxib and diclofenac in rheumatoid arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Diclofenac (diclofenac)
• Etoricoxib (etoricoxib)

Snippet

Sponsor: Northumbria Healthcare NHS Foundation Trust | Conditions: Rheumatoid Arthritis | Phase 4 | Status: WITHDRAWN